Gene · 84433
Papers2,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phosphatases in tumor cell immune escape: a perspective based on the camouflage, coercion, cytoprotection. | Front Cell Dev Biol | 2026 | 41799437 | PubTator, text mining | PubMed |
| A single-center retrospective study suggests a potential benefit of BTK inhibitor-based therapy in patients with histologic transformation of Waldenström macroglobulinemia. | Ann Med | 2026 | 41797694 | PubTator, text mining | PubMed |
| Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China. | Ann Hematol | 2026 | 41793484 | PubTator, text mining | PubMed |
| Understanding hairy cell leukemia in the context of mature B-cell neoplasms: tumor microenvironment and extracellular vesicle contribution to disease pathogenesis. | Front Immunol | 2026 | 41789071 | PubTator, text mining | PubMed |
| Next-generation sequencing for DLBCL patients with early failure after frontline R-CHOP chemo-immunotherapy. | Front Oncol | 2026 | 41788999 | PubTator, text mining | PubMed |
| Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects. | J Cell Commun Signal | 2026 | 41783325 | PubTator, text mining | PubMed |
| Oncostatin M receptor deficiency as a novel candidate genetic cause of autosomal recessive hyper-IgE syndrome. | J Hum Immun | 2026 | 41783139 | PubTator, text mining | PubMed |
| Large B-cell Lymphoma With IRF4 Rearrangement in the Elderly. | Cureus | 2026 | 41755940 | PubTator, text mining | PubMed |
| Prime Editing Driven Functional Genomics: Bridging Genotype to Phenotype in the Post-Genomic Era. | Int J Mol Sci | 2026 | 41751840 | PubTator, text mining | PubMed |
| Immune escape mechanisms and therapeutic advances in virus-associated hematological malignancies. | Blood Cancer J | 2026 | 41741411 | PubTator, text mining | PubMed |
| Research on the correlation and potential mechanism of PKCδ expression with efficacy and prognosis in diffuse large B-cell lymphoma. | Front Oncol | 2026 | 41727647 | PubTator, text mining | PubMed |
| Mechanisms of resistance to bruton's tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways. | Ann Hematol | 2026 | 41721839 | PubTator, text mining | PubMed |
| Platelets as immune sensors: monitoring immune dynamics and diagnosing disease states across multiple disorders. | EBioMedicine | 2026 | 41719795 | PubTator, text mining | PubMed |
| The interaction between dendritic cells and T follicular helper cells drives inflammatory bowel disease: a review. | Front Immunol | 2026 | 41710888 | PubTator, text mining | PubMed |
| Targeted deep sequencing identifies mosaicism in patients with immune dysregulation. | J Allergy Clin Immunol | 2026 | 41654260 | PubTator, text mining | PubMed |
| Diverse transcriptomic and mutational patterns but limited functional pathway alterations in patient-derived Sézary syndrome cells. | J Invest Dermatol | 2026 | 41644084 | PubTator, text mining | PubMed |
| Epigenetic dysregulation of B‑cells in autoimmune diseases and lymphomas (Review). | Int J Mol Med | 2026 | 41574706 | PubTator, text mining | PubMed |
| Application of the STAAR framework in detecting rare variant associations with Alzheimer disease and related dementias: Insights and implications. | HGG Adv | 2026 | 41560352 | PubTator, text mining | PubMed |
| COVID-19 immunopathological features for the prediction and prevention of future emerging respiratory viral infections. | Comput Struct Biotechnol J | 2026 | 41551039 | PubTator, text mining | PubMed |
A Phase 1 Dose-Escalation, Food Effect, and Drug-Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy Volunteers. | Clin Pharmacol Drug Dev | 2026 | 41549795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84433/papers?page=2